Could isoenzyme-selective phosphodiesterase inhibitors render bronchodilator therapy redundant in the treatment of bronchial asthma?
- 1 May 1992
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 43 (10) , 2041-2051
- https://doi.org/10.1016/0006-2952(92)90160-k
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Prospects for selective cyclic nucleotide phosphodiesterase inhibitors in the treatment of bronchial asthmaClinical and Experimental Allergy, 1992
- Phosphodiesterase inhibitors: new opportunities for the treatment of asthma.Thorax, 1991
- Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitorsTrends in Pharmacological Sciences, 1990
- Human Recombinant Lymphokines and Cytokines Induce Pulmonary Eosinophilia in the Guinea Pig which Is Inhibited by Ketotifen and AH 21–132International Archives of Allergy and Immunology, 1990
- High pressure liquid chromatography of cyclic nucleotide phosphodiesterase from purified human T-lymphocytesBiochemical and Biophysical Research Communications, 1989
- PRESCRIBED FENOTEROL AND DEATH FROM ASTHMA IN NEW ZEALAND, 1981-83; CASE-CONTROL STUDYThe Lancet, 1989
- HAS THE MANAGEMENT OF ASTHMA IMPROVED?The Lancet, 1987
- Phospholipid and arachidonic acid metabolism in zymosan‐stimulated human monocytes: Modulation by cAMPJournal of Cellular Physiology, 1987
- Prevalence of asthma and hay fever in England and Wales.BMJ, 1987
- Mechanisms of Lysosomal Enzyme Release from Human Leukocytes II. EFFECTS OF cAMP AND cGMP, AUTONOMIC AGONISTS, AND AGENTS WHICH AFFECT MICROTUBULE FUNCTIONJournal of Clinical Investigation, 1974